New England 2016 Annual Life Sciences Panorama [fr]
Life sciences & business leaders from France & USA weigh in on New England’s momentum, opportunities & challenges in the year ahead.
In 2015, New England continued to play a major global role in Biotechnology and Life Sciences as the creation of companies, IPOs, mergers and acquisitions, and evolution of local real estate show it. These rising figures reflected an industry-wide focus on drugs dedicated to the treatment of rare diseases and specializing in key areas of critically unmet medical needs.
On Tuesday, March 15, join New England’s French-American Chamber of Commerce and the French American Biotech Springboard at 6:00 pm, at the Sanofi Genzyme Center, to meet local MA companies as well as researchers, sciences & business leaders from both sides of the Atlantic as they analyze fast-changing developments in Life Sciences both in New England and in Europe. For the third consecutive year, this must-attend program will address core topics of interest for both young and large companies, and offers networking opportunities for biopharma professionals. Topics will include an expert review of events, perspectives on the upcoming year, trends in finance and investment, discussions around innovation and new technologies, along with how to bring these to the patients.
Where: Sanofi Genzyme Center, 500 Kendall Street, Cambridge, MA 02142
When: March 15, 6:00 pm – 9:00 pm
Admission: $35 (FACCNE Members and Partners); $20 (Students and YP Members); $50 (non-members)
Register now on the FACCNE website.
Organized by FACCNE, the French American Biotech Springboard, in partnership with the Sanofi Genzyme Center.
Full program is right here: